Aerie pharmaceuticals, inc. (AERI)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12
Total revenues, net

20,341

24,657

18,544

15,835

10,852

14,456

7,302

2,423

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Cost of goods sold

6,092

1,684

2,063

705

381

377

205

59

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Costs and expenses:
Selling, general and administrative

36,902

35,467

32,171

34,482

36,282

31,887

32,685

33,112

22,930

5,503

19,774

17,153

14,475

4,892

10,627

9,386

9,801

7,648

7,462

7,502

8,023

6,380

4,944

5,167

3,612

3,594

3,287

1,940

1,466

1,416

Pre-approval commercial manufacturing

2,114

-

-

-

4,457

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Pre-approval commercial manufacturing

-

-

5,841

5,819

-

7,625

7,248

6,779

4,893

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development

19,173

30,794

21,796

20,904

17,884

26,492

28,502

18,157

12,972

38,101

12,408

10,615

10,954

14,093

12,688

13,304

12,309

12,302

9,904

10,627

11,618

9,593

8,230

6,676

5,370

3,156

2,399

3,173

3,155

1,373

Total costs and expenses

64,281

74,595

61,871

61,910

59,004

66,381

68,640

58,107

40,795

60,314

32,182

27,768

25,429

-

23,315

22,690

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss from operations

-43,940

-49,938

-43,327

-46,075

-48,152

-51,925

-61,338

-55,684

-40,795

-60,314

-32,182

-27,768

-25,429

-28,757

-23,315

-22,690

-22,110

-19,950

-17,366

-18,129

-19,641

-15,973

-13,174

-11,843

-8,982

-6,750

-5,686

-5,113

-4,621

-2,789

Other (expense) income, net

-5,222

-5,126

-6,075

-1,089

111

467

-24,050

663

96

-99

-141

-618

-312

-504

-460

-482

-548

-512

-523

-505

2,402

-528

27

29

2,311

-3,532

-5,062

-1,215

831

-803

Loss before income taxes

-49,162

-55,064

-49,402

-47,164

-48,041

-51,458

-85,388

-55,021

-40,699

-60,413

-32,323

-28,386

-25,741

-29,261

-23,775

-23,172

-22,658

-20,462

-17,889

-18,634

-17,239

-

-13,147

-11,814

-

-

-

-

-

-

Income tax (benefit) expense

-33

0

0

0

-90

0

0

3

0

-1,900

49

47

46

61

39

47

46

-85

72

152

0

-

0

0

-

-

-

-

-

-

Net loss

-49,129

-55,064

-49,402

-47,164

-47,951

-51,458

-85,388

-55,024

-40,699

-58,513

-32,372

-28,433

-25,787

-29,322

-23,814

-23,219

-22,704

-20,377

-17,961

-18,786

-17,239

-16,501

-13,147

-11,814

-6,671

-10,282

-10,748

-6,328

-3,790

-3,592

Net loss attributable to common stockholdersbasic and diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-22,704

-

-17,961

-18,786

-17,239

-16,501

-13,147

-11,814

-6,671

-10,319

-10,887

-6,465

-3,927

-3,730

Net loss per common share—basic and diluted (in dollars per share)

-1.07

-1.20

-1.09

-1.04

-1.06

-1.17

-1.96

-1.40

-1.05

-1.64

-0.89

-0.82

-0.76

-0.87

-0.81

-0.87

-0.85

-0.76

-0.69

-0.73

-0.70

-0.69

-0.54

-0.49

-0.28

15.09

-10.81

-6.59

-4.07

-3.87

Weighted average number of common shares outstanding—basic and diluted (in shares)

45,792

45,592

45,448

45,397

45,270

45,194

43,657

39,204

38,598

36,526

36,210

34,783

33,777

33,665

29,380

26,773

26,723

26,618

26,061

25,841

24,602

24,410

24,325

23,893

23,717

16,869

1,006

981

965

964

Net loss

-49,129

-55,064

-49,402

-47,164

-47,951

-51,458

-85,388

-55,024

-40,699

-58,513

-32,372

-28,433

-25,787

-29,322

-23,814

-23,219

-22,704

-20,377

-17,961

-18,786

-17,239

-16,501

-13,147

-11,814

-6,671

-10,282

-10,748

-6,328

-3,790

-3,592

Unrealized (loss) gain on available-for-sale investments

-28

66

-158

0

0

1

8

148

-129

70

-17

24

-37

-55

-3

58

111

-147

9

17

49

-98

4

8

-21

-

-

-

-

-

Comprehensive loss

-49,157

-54,998

-49,560

-47,164

-47,951

-51,457

-85,380

-54,876

-40,828

-58,443

-32,389

-28,409

-25,824

-29,377

-23,817

-23,161

-22,593

-20,524

-17,952

-18,769

-17,190

-16,599

-13,143

-11,806

-6,692

-10,282

-10,748

-6,328

-3,790

-3,592

Product revenues, net
Total revenues, net

20,341

24,657

18,544

15,835

10,852

14,456

7,302

2,423

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-